Hiroshi Nakajima

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 31

Top Venues

RMD open

Proceedings of the National Academy of Sciences of the United States of America

Seminars in immunopathology

Nature communications

Chiba University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chiba University

Japan

Professor :: Allergy and Clinical Immunology

Publications

Takashi Kumagai, Arifumi Iwata, Hiroki Furuya, Kodai Kato, Atsushi Okabe, Yosuke Toda, Mizuki Kanai, Lisa Fujimura, Akemi Sakamoto, Takahiro Kageyama, Shigeru Tanaka, Akira Suto, Masahiko Hatano, Atsushi Kaneda, Hiroshi Nakajima
A distal enhancer of GATA3 regulates Th2 differentiation and allergic inflammation. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Hiroki Furuya, Yosuke Toda, Arifumi Iwata, Mizuki Kanai, Kodai Kato, Takashi Kumagai, Takahiro Kageyama, Shigeru Tanaka, Lisa Fujimura, Akemi Sakamoto, Masahiko Hatano, Akira Suto, Kotaro Suzuki, Hiroshi Nakajima
Stage-specific GATA3 induction promotes ILC2 development after lineage commitment. Nature communications 15 (1) (2024)
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, Hiroshi Nakajima
Physiological and immunological barriers in the lung. Seminars in immunopathology 45 (4-6) (2024)
Hiroki Furuya, Yosuke Toda, Arifumi Iwata, Mizuki Kanai, Kodai Kato, Takashi Kumagai, Takahiro Kageyama, Shigeru Tanaka, Lisa Fujimura, Akemi Sakamoto, Masahiko Hatano, Akira Suto, Kotaro Suzuki, Hiroshi Nakajima
Stage-specific GATA3 induction promotes ILC2 development after lineage commitment. Nature communications 15 (1) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Hiroki Furuya, Yosuke Toda, Arifumi Iwata, Mizuki Kanai, Kodai Kato, Takashi Kumagai, Takahiro Kageyama, Shigeru Tanaka, Lisa Fujimura, Akemi Sakamoto, Masahiko Hatano, Akira Suto, Kotaro Suzuki, Hiroshi Nakajima
Stage-specific GATA3 induction promotes ILC2 development after lineage commitment. Nature communications 15 (1) (2024)
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, Hiroshi Nakajima
Physiological and immunological barriers in the lung. Seminars in immunopathology 45 (4-6) (2024)
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, Hiroshi Nakajima
Physiological and immunological barriers in the lung. Seminars in immunopathology (2024)
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, Hiroshi Nakajima
Physiological and immunological barriers in the lung. Seminars in immunopathology 45 (4-6) (2024)
Takashi Kumagai, Arifumi Iwata, Hiroki Furuya, Kodai Kato, Atsushi Okabe, Yosuke Toda, Mizuki Kanai, Lisa Fujimura, Akemi Sakamoto, Takahiro Kageyama, Shigeru Tanaka, Akira Suto, Masahiko Hatano, Atsushi Kaneda, Hiroshi Nakajima
A distal enhancer of GATA3 regulates Th2 differentiation and allergic inflammation. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Takashi Kumagai, Arifumi Iwata, Hiroki Furuya, Kodai Kato, Atsushi Okabe, Yosuke Toda, Mizuki Kanai, Lisa Fujimura, Akemi Sakamoto, Takahiro Kageyama, Shigeru Tanaka, Akira Suto, Masahiko Hatano, Atsushi Kaneda, Hiroshi Nakajima
A distal enhancer of GATA3 regulates Th2 differentiation and allergic inflammation. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD open 9 (1) (2023)
Ryohei Ono, Togo Iwahana, Shuji Toriumi, Kaoruko Aoki, Hirotoshi Kato, Kodai Kato, Masahiro Yasui, Yuzuho Nakagawa, Shunsuke Furuta, Hiroshi Nakajima, Yoshio Kobayashi
Fulminant myocarditis with adult-onset Still's disease: case-based review. Clinical rheumatology (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Shunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-Ichiro Kagami, Yosuke Inaba, Hideki Hanaoka, Kei Ikeda, Hiroshi Nakajima, null null
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study. Annals of the rheumatic diseases (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD open 9 (1) (2023)
Chiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, Sanae Ikehara, Kazuhiko Azuma, Tadanaga Shimada, Sachiko Kuriyama, Syota Ohki, Emiri Yamamoto, Yosuke Inaba, Yuki Shiko, Ami Aoki, Kota Kokubo, Rui Hirasawa, Takahisa Hishiya, Kaori Tsuji, Tetsutaro Nagaoka, Satoru Ishikawa, Akira Kojima, Haruki Mito, Ryota Hase, Yasunori Kasahara, Naohide Kuriyama, Tetsuya Tsukamoto, Sukeyuki Nakamura, Takashi Urushibara, Satoru Kaneda, Seiichiro Sakao, Minoru Tobiume, Yoshio Suzuki, Mitsuhiro Tsujiwaki, Terufumi Kubo, Tadashi Hasegawa, Hiroshi Nakase, Osamu Nishida, Kazuhisa Takahashi, Komei Baba, Yoko Iizumi, Toshiya Okazaki, Toshinori Nakayama, Ichiro Yoshino, Hidetoshi Igari, Hiroshi Nakajima, Takuji Suzuki, Hideki Hanaoka, Taka-Aki Nakada, Yuzuru Ikehara, Koutaro Yokote, Toshinori Nakayama
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity. Proceedings of the National Academy of Sciences of the United States of America 119 (33) (2022)
Katsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, Shinsuke Fujita, Hiroshi Nakajima, Hideki Hanaoka, Takahiro Suzuki
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study. Modern rheumatology 32 (5) (2022)
Chie Kohno, Kayoko Kaneko, Kunihiko Takahashi, Yukihiro Ohya, Hiroshi Nakajima, Atsuko Murashima
Intrauterine exposure to immunosuppressants influences the development of postnatal allergic diseases. Allergy 76 (9) (2021)
Koichi Hirose, Arifumi Iwata, Tomohiro Tamachi, Hiroshi Nakajima
Allergic airway inflammation: key players beyond the Th2 cell pathway. Immunological reviews 278 (1) (2018)
Shigeru Tanaka, Akira Suto, Taro Iwamoto, Takahiro Kageyama, Tomohiro Tamachi, Hiroaki Takatori, Kotaro Suzuki, Koichi Hirose, Osamu Ohara, Véronique Lefebvre, Hiroshi Nakajima
Sox12 promotes T reg differentiation in the periphery during colitis. The Journal of experimental medicine 215 (10) (2018)

Hiroshi Nakajima.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroshi Nakajima